Yu Lab

_{Aastha received her M.S. in translational biotechnology from the University of Southern California in 2021. Prior to her current position, she worked at Vaxcyte, San Carlos, CA. Her role was to perform DoE in downstream process development of carrier protein of the pneumococcal conjugate vaccine candidate. She joined the Yu Lab to investigate temporo-spatial epigenetic regulation leveraging  the dTAG protein degradation system.}

_{Chen-I received his M.S. from National Cheng-Kung University, where he studied disease mechanisms of polycystic ovary syndrome. As a Ph.D. student, he is interested in understanding how euchromatin is established in the context of development and cancer.}

_{Sarah received her Ph.D. in chemical biology from the University of California, Irvine in 2024. During her doctoral research, Sarah studied the role of beta-hairpins in amyloid-beta oligomerization and toxicity using peptide model systems and human iPSC-derived neurons. As a postdoctoral fellow, Sarah is investigating mechanisms of chromatin imbalance and their role in neurodevelopmental disorders.}

_{Mahnue received her B.S. in Biomolecular Sciences from Central Connecticut State University in 2022 and has recently completed a 2-year Postbac program at NIH. She is currently leveraging CRISPR/Cas9 technology to interrogate the interplay between nuclear organelles and chromatin-modifying enzymes.}

_{Anamika received her Ph.D. in biochemistry from the Indian Institute of Technology (IIT) Roorkee. Prior to joining Yu lab as a research associate, she conducted her postdoctoral trainings in Hebrew University of Jerusalem in Israel and Oregon State University. Her expertise includes in vitro biochemistry and assay development. In the Yu Lab, she is currently investigating the role of SPIN4 in epigenetic regulation in collaboration with Dr. Youn Hee Jee (Children’s National) and PRC2 non-histone substrates..}